Rodman & Renshaw, LLC Announces Investment Opinion: Rodman & Renshaw, LLC Initiates Coverage of BioSante Pharmaceuticals with a
07 October 2005 - 6:34AM
Business Wire
Rodman & Renshaw, LLC initiated research coverage of BioSante
Pharmaceuticals (AMEX: BPA) with a Market Outperform Rating and a
12-month price target $7. Ilya Kravets, Senior Specialty
Pharmaceuticals Analyst, issued the report. About Rodman &
Renshaw, LLC Rodman & Renshaw is a privately held, full-service
investment bank committed to fostering the long-term success of
growth companies through capital raising, strategic advice,
insightful research, and the development of institutional support.
More information is available at www.rodmanandrenshaw.com None of
the research analysts or the research analyst's household has a
financial interest in the securities of BioSante Pharmaceuticals
(including, without limitation, any option, right, warrant, future,
long or short position). As of August 31, 2005, neither Rodman
& Renshaw, LLC nor its affiliates beneficially own 1% or more
of any class of common equity securities of BioSante
Pharmaceuticals. Neither the research analyst nor Rodman &
Renshaw, LLC has any material conflict of interest with BioSante
Pharmaceuticals, of which the research analyst knows or has reason
to know at the time of publication of this research report. Rodman
& Renshaw, LLC or its affiliates did not receive compensation
from BioSante Pharmaceuticals for investment banking services
within the last twelve months and Rodman & Renshaw, LLC intends
to seek compensation from BioSante Pharmaceuticals for investment
banking services within three months, following publication of the
research report. Neither the research analyst nor any member of the
research analyst's household nor Rodman & Renshaw, LLC serves
as an officer, director or advisory board member of BioSante
Pharmaceuticals. Rodman & Renshaw, LLC does not make a market
in BioSante Pharmaceuticals' securities as of the date of this
research report. The above information is not intended to be used
as a primary basis of investment decisions. It is not a
representation by Rodman & Renshaw, LLC or an offer or the
solicitation of an offer to buy any security. Before investing in
BioSante Pharmaceuticals, you should carefully consider your risk
tolerance and financial objectives.
Biosante Pharma (AMEX:BPA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biosante Pharma (AMEX:BPA)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Biosante Pharmaceuticals (American Stock Exchange): 0 recent articles
More Rodman & Renshaw, LLC News Articles